Talima Therapeutics, Inc. Report issue

For profit Phase 2
Founded: San Carlos CA United States (2004)
Status: Defunct (2011)

Organization Overview

First Clinical Trial
2009
NCT01093118
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

methimazole (tapazole) (1 trial)

tmi-358 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Onychomycosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2